For comments, suggestions
Created with Raphaël 2.1.0 14.08.2020 Filing date 03.03.2022 Validation fee payment 31.07.2022 (A1) Patent application published 03.01.2025 Can request protection in MD until

Patent not validated (the request for validation was not submitted on time)


(210)Number of the EPO application20765121
(220)Filing date of the EPO application2020.08.14
(80)EPO patent specification publication (B)EPB nr. 27/2024, 2024.07.03
(110)EPO patent number4013385
(21)Number of the applicatione 2022 0704
(71)Name(s) of applicant(s), code of the countryAcuitas Therapeutics, Inc., CA;
(72)Name(s) of inventor(s), code of the countryTAM Ying K., CA;
LIN Paulo Jia Ching, CA;
SEMPLE Sean, CA;
BARBOSA Christopher J., CA;
(73)Name(s) of owner(s), code of the countryAcuitas Therapeutics, Inc., CA;
(54)Title of the inventionIMPROVED LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS
(13)Kind-of-document code A1
(51)International Patent Classification A61K 9/00 (2006.01.01); A61K 9/127 (2006.01.01)
(19)CountryCA
(41)Date of publication of the application2022.07.31
(30)Priority201962886894 P, 2019.08.14, US
(86)International applicationPCT/US2020/046407, 2020.08.14
(87)International publicationWO 2021/030701, 2021.02.18
Up
/Inventions/details/4013385